Mille-Loera JE, Portela-Ortiz JM, Aréchiga-OrnelasG

Language: Spanish
References: 10
Page: 90-94
PDF size: 502.22 Kb.

Text Extraction

No abstract

REFERENCES

1. Calatayud J, González A. History of the development and evolution of local anesthesia since the coca leaf. Anesthesiology 2003;98:1503-1508.

2. Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 1979;51:285-287.

3. Valenzuela C, Snyders DJ, Bennett PB. Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes. Circulation 1995;92:3014-3024.

4. Kawano T, Oshita S, Takahashi A. Molecular mechanisms of the inhibitory effects of bupivacaine, levobupivacaine and ropivacaine on sarcolemmal adenosine triphosphato-sensitive potassium channels in the cardiovascular system. Anesthesiology 2004;101:390-398.

5. Moller R, Covino BG. Cardiac electrophysiologic properties of bupivacaine and lidocaine compared with those of ropivacaine, a new amide local anesthetic. Anesthesiology 1990;72:322-329.

6. Neal JM, Bernards CM, Butterworth JF. ASRA practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med 2010;35:152-161.

7. Espinoza AM. Intoxicación por anestésicos locales y utilidad de los lípidos al 20%. Rev Chil Anest 2010;39:76-84.

8. Bourne E, Wrigth Ch, Royse C. A review of local anesthetic cardiotoxicity and treatment with lipid emulsion. Loc Reg Anesth 2010;3:11-19.

9. Di Gregorio G, Neal JM, Rosenquist RW. Clinical presentation of local anesthetic systemic toxicity: a review of published cases 1979 to 2009. Reg Anesth Pain Med 2010;35:181-187.

10. Weinberg GL. Treatment of local anesthetic systemic toxicity (LAST). Reg Anesth Pain Med 2010;35:188-193.